Australia's most trusted source of pharma news
Friday, 03 July 2020
Lost Your Access?
USyd enters Covid vax race
Combines older BCG vax with SARS-CoV-2 virus
Celebs plug plasma therapy
CSL's Covid treatment gets high-powered support
'New normal' here to stay
Which staff anticipate the biggest change?
Roche SMA drug double ticked
Orphan, priority review as docs prep awareness
Sanofi seals blood deal
Two new haemophilia treatments on NBA
Eylea biosim pushes forward
Biogen has local rights to phase 3 drug
Pharma job fears remain
Office return has not provided reassurance
Roche staff to go 'agile'
Flags role changes on the horizon in shakeup
Reps do return to road dance
But not all doctor's are welcoming them back
GPs want rep visits, not calls
Docs tell pharma how they want to interact
Social the pharma office perk
But is workplace fun worth the commute?
Patient orgs pushed to brink
Workload spikes, fearful patients, funding shortfalls
Scripts settle after Covid high
Big drop follows early stockpiling rush
Bexsero gets small NIP berth
GSK's vaccine to be free for certain populations
Guild weighs in on shorts
Room for local manufacturing as stockpiling eases
Janssen in HIV court fight
Alleges infringement of
Hunt hits jargon favourites
How many of these political lines have you heard?
Top of the Hill
Call me, unless you're a rep
Docs are fussy when it comes to phones
New Italian COPD drug
Emerge Health's acquisition brings triplet therapy.
Vaccine progress in Aust
A local look at where candidates are at
© 2003 - 2020 Lush Media
Pharma in Focus
Jolly Good Design